The glutamate transport inhibitor dl-Threo--benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cells
Chicago Arthritis's overview of GLP-1, CJC-1295, AOD-9604, and related peptides lists nausea, headaches, and fluid retention as possible side effects and stresses that any peptide plan, especially a combined or "stacked" protocol, needs to be built and monitored by a knowledgeable physician (chicagoarthritis.com)
This means it stays active longer and is easier for the body to use
24 Cosmetics On December 29, 2022, the Modernization of Cosmetics Regulation Act (MoCRA) was signed into law expanding FDAs regulatory authority over cosmetic products
Oral capsules: maximum 500 micrograms (0.5 milligrams)/day/2 times a day
Biondini, N